Analyst Ratings for Aclaris Therapeutis (ACRS) [Neutrals]
ACRS Rating Summary
ACRS Price Target Summary
- Highest: $3.00 (Evercore ISI)
- Lowest: $1.00 (Jefferies)
- Average: $1.80
* Over Last 12-Mos
Overall Rating:
NEUTRAL
Rating Trend:
=
Avg. $ Target:
$1.80 (+51.3%)
* Over Last 12-Mos
Rating Score: 3.1 / 10
Percentile Rank: 27%
Rating Score: 3.1 / 10
Percentile Rank: 27%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 1/22/2024 | H.C. Wainwright | Raghuram Selvaraju | Downgrade | Neutral (Buy) |
N/A (N/A) |
1.14 (1.19) |
4.39% | Details |
| 1/11/2024 | BTIG | Julian Harrison | Downgrade | Neutral (Buy) |
N/A (N/A) |
1.01 (1.19) |
17.82% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
